Bright Eye Hospital Group Co., Ltd. (SHE:301239)
45.20
+0.10 (0.22%)
At close: Apr 29, 2026
Bright Eye Hospital Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2018 |
| Net Income | -10.35 | -53.72 | -101.86 | 267.91 | 20.57 | 93.89 | Upgrade
|
| Depreciation & Amortization | 333.2 | 333.2 | 311.36 | 273.82 | 214.82 | 177.71 | Upgrade
|
| Other Amortization | 90.11 | 90.11 | 88.03 | 68.89 | 51.99 | 42.89 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | 0.93 | -0.06 | -0.56 | -0.93 | Upgrade
|
| Asset Writedown & Restructuring Costs | 11.17 | 11.17 | 6 | 0.47 | 2.12 | 8.62 | Upgrade
|
| Loss (Gain) From Sale of Investments | 10.89 | 10.89 | 3.51 | -78.29 | -12.6 | -9.47 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -0.22 | 3.37 | 1.59 | - | Upgrade
|
| Other Operating Activities | 25.28 | 85.84 | 98.18 | 88.57 | 60.4 | 52.47 | Upgrade
|
| Change in Accounts Receivable | -4.24 | -4.24 | 4.04 | -23.18 | -13.26 | -5.11 | Upgrade
|
| Change in Inventory | -57.14 | -57.14 | 2.28 | -45.68 | -18.95 | -12.18 | Upgrade
|
| Change in Accounts Payable | 124.31 | 124.31 | -24.32 | 63.97 | 18.09 | 13.41 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | -3.24 | - | 1.63 | Upgrade
|
| Operating Cash Flow | 527.67 | 544.86 | 382.43 | 614.46 | 319.3 | 359.42 | Upgrade
|
| Operating Cash Flow Growth | 16.90% | 42.47% | -37.76% | 92.44% | -11.16% | 57.98% | Upgrade
|
| Capital Expenditures | -205.88 | -226.41 | -542.86 | -626.87 | -327.99 | -254.8 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.68 | 4.84 | 1.45 | 0.22 | 1.02 | 1.76 | Upgrade
|
| Cash Acquisitions | -91.85 | -25.05 | -5 | 88.53 | - | -168.7 | Upgrade
|
| Investment in Securities | -123.62 | -202.13 | -8.63 | -29.24 | -274.91 | -7.6 | Upgrade
|
| Other Investing Activities | 2.02 | 1.56 | 1.66 | -1.02 | - | - | Upgrade
|
| Investing Cash Flow | -414.66 | -447.19 | -553.38 | -568.38 | -601.88 | -429.47 | Upgrade
|
| Long-Term Debt Issued | - | 196.5 | 550.13 | 282.8 | 202.5 | 110 | Upgrade
|
| Total Debt Issued | 260.24 | 196.5 | 550.13 | 282.8 | 202.5 | 110 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0.58 | Upgrade
|
| Long-Term Debt Repaid | - | -199.52 | -579.31 | -391.52 | -259.13 | -149.15 | Upgrade
|
| Total Debt Repaid | -185.25 | -199.52 | -579.31 | -391.52 | -259.13 | -149.73 | Upgrade
|
| Net Debt Issued (Repaid) | 75 | -3.02 | -29.18 | -108.72 | -56.63 | -39.73 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,152 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -29.8 | -29.98 | - | - | Upgrade
|
| Common Dividends Paid | -18.93 | -17.75 | -77.97 | -27.63 | -9.04 | -4.55 | Upgrade
|
| Other Financing Activities | -235.03 | -218.63 | -17.82 | - | -47.94 | - | Upgrade
|
| Financing Cash Flow | -178.97 | -239.4 | -154.78 | -166.33 | 1,038 | -44.28 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | 0.02 | 0.1 | -0.41 | -0.29 | -0 | Upgrade
|
| Net Cash Flow | -65.94 | -141.72 | -325.63 | -120.65 | 755.46 | -114.33 | Upgrade
|
| Free Cash Flow | 321.79 | 318.45 | -160.43 | -12.41 | -8.68 | 104.62 | Upgrade
|
| Free Cash Flow Growth | 467.09% | - | - | - | - | 29.30% | Upgrade
|
| Free Cash Flow Margin | 11.19% | 11.38% | -5.99% | -0.46% | -0.50% | 6.12% | Upgrade
|
| Free Cash Flow Per Share | 2.17 | 2.14 | -1.07 | -0.08 | -0.07 | 0.94 | Upgrade
|
| Cash Income Tax Paid | 71.16 | 73.62 | 139.54 | 96.41 | 58.08 | 65.41 | Upgrade
|
| Levered Free Cash Flow | 263.74 | 224.87 | -216.59 | 78.63 | 1.6 | 66.15 | Upgrade
|
| Unlevered Free Cash Flow | 263.74 | 224.87 | -162.16 | 125.29 | 37.58 | 96.43 | Upgrade
|
| Change in Working Capital | 67.36 | 67.36 | -23.5 | -10.23 | -19.03 | -5.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.